Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

(2020) W. Timothy Garvey et al.   DIABETES CARE

Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial

(2020) Thomas A. Wadden et al.   Obesity

Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada

(2019) Sean Wharton et al.   Obesity

Incorporating and Interpreting Regulatory Guidance on Estimands in Diabetes Clinical Trials: The PIONEER 1 Randomized Clinical Trial as an Example

(2019) Vanita R. Aroda et al.   DIABETES OBESITY & METABOLISM

Smoking and weight loss among smokers with overweight and obesity in Look AHEAD.

(2018) Cara M. Murphy et al.   HEALTH PSYCHOLOGY

The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial

(2016) Wilma S. Leslie et al.   BMC Family Practice

The effect of tobacco cessation on weight gain, obesity, and diabetes risk

(2016) Terry Bush et al.   Obesity

The Relationship between Body Mass Index and Post-Cessation Weight Gain in the Year after Quitting Smoking: A Cross-Sectional Study

(2016) Rebecca A. Krukowski et al.   PLoS One

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

(2015) Melanie J. Davies et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Missing data in clinical trials for weight management

(2015) Bradley W. McEvoy   Journal of Biopharmaceutical Statistics

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

(2015) Xavier Pi-Sunyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is drop-out from obesity treatment a predictable and preventable event?

(2014) Ottavia Colombo et al.   Nutrition Journal

Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity

(2013) Michael Lean et al.   BRITISH JOURNAL OF GENERAL PRACTICE

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

(2013) T A Wadden et al.   INTERNATIONAL JOURNAL OF OBESITY

The Prevention and Treatment of Missing Data in Clinical Trials

(2012) Roderick J. Little et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

(2011) A Astrup et al.   INTERNATIONAL JOURNAL OF OBESITY

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Missing Data in Randomized Clinical Trials for Weight Loss: Scope of the Problem, State of the Field, and Performance of Statistical Methods

(2009) Mai A. Elobeid et al.   PLoS One